Advertisement
The major product segments analyzed in the report are Endoscopes andVisualization Equipment for the screening, diagnosis, treatment and managementof medical conditions. The report points to Solos Endoscopy for its patentedbreast endoscopy system, as well as its agreements with Dynamic SurgicalInventions, Tekno-Medical, and the filing for FDA clearance of the SolosEndoscopy OvaScope(TM) and MastaScope(TM).
Advertisement
"This is great exposure for our company, and we expect that our inclusionwill increase the worldwide exposure to our products among industry expertsand analysts. We have put a great amount of effort and resources into thedevelopment of our technologies, and it is refreshing to see our flagshipproducts included in this report," stated Bob Segersten, President of SolosEndoscopy, Inc.
To view the article referencing the report and a synopsis of the reportitself, please visit the following link on MSNBC.com:www.msnbc.msn.com/id/26549899.
Solos Endoscopy continues to develop its MammoView(TM) line of breastendoscopy products, a next generation breast endoscopy system that includes anew family of endoscopes and instrumentation. This product line brings severalimportant advantages, including reduced production costs, lower price-per-procedure to customers and the ability to facilitate a far broader range ofbreast cancer treatment methodologies. It has signed several more breastcenters as new accounts in recent months to utilize the MammoView, and expectsthis new product line to make a major contribution to its revenue base in thecoming year.
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a healthcare technology company whose mission isto develop and market breakthrough technology, applications, medical devices,and procedural techniques for the screening, diagnosis, treatment andmanagement of medical conditions. Backed by technical support, Solos' salesteam can help make the right buying decisions for the hospital, surgerycenter, or physician office. Additional information is available on theCompany's website at: www.solosendoscopy.com.
Safe Harbor: This release includes forward-looking statements within themeaning of Section 27A of the Securities Act of 1933 and Section 27E of theSecurities Act of 1934. Statements contained in this release that are nothistorical facts may be deemed to be forward-looking statements. Investors arecautioned that forward-looking statements are inherently uncertain. Actualperformance and results may differ materially from that projected or suggestedherein due to certain risks and uncertainties including, without limitation,ability to obtain financing and regulatory and shareholder approval foranticipated actions.
SOURCE Solos Endoscopy, Inc.
